|
1
|
|
|
2
|
- Serum [Na+] is a surrogate marker for serum osmolality
- Na+ concentration =
|
|
3
|
|
|
4
|
|
|
5
|
|
|
6
|
|
|
7
|
|
|
8
|
|
|
9
|
|
|
10
|
|
|
11
|
|
|
12
|
- A 70 yr old smoker presents with cough and hemoptysis. On exam he is
euvolemic. CXR shows a solitary lung nodule.
- Na 114 K 4 Cl 88 HCO3
20
- Glucose 110 BUN 9 Cr 0.8
- TSH normal
- Urine osmolality 650
- What is the likely cause of his hyponatremia?
|
|
13
|
|
|
14
|
- Diagnosis: SIADH, probably from lung cancer.
|
|
15
|
- Isotonic saline
- Water restriction
- Water restriction
- If UNa+UK<150: Isotonic saline
- Hypertonic saline/Na tablets
- Furosemide
- Demecocycline
- Hypovolemia
- Polydipsia
- SIADH
- Mild cases
|
|
16
|
|
|
17
|
|
|
18
|
|
|
19
|
|
|
20
|
|
|
21
|
|
|
22
|
- Isotonic saline
- Water restriction
- Water restriction
- If UNa+UK<150: Isotonic saline
- Hypertonic saline/Na tablets
- Furosemide
- Demecocycline
- Hypovolemia
- Polydipsia
- SIADH
- Mild cases
|
|
23
|
- Acute (< 48 hr) or symptomatic
- Chronic (> 48 hr) including SIADH and asymptomatic
- Do not exceed Δ 12 mEq/L in 1st day or correct to ~
120-125 mEq/L.
|
|
24
|
- Deficit in mmol = 0.5 x BW [120-Na]
- Hypertonic saline contains 513 mEq/L Na
- Volume of 3% saline required (in L) = Deficit/500
- Volume of 3% saline required (in mL) = Deficit x 2
- Quick check: Each Δ of 1 mEq/L requires ~ 70 ml hypertonic saline.
|
|
25
|
- Bodt weight 70 kg
- Serum Na 114
- Urine lytes:
- Osmolality 650 Na 120 K 80
- How would you manage his hyponatremia?
|
|
26
|
- Chronic asymptomatic hyponatremia
- First line Rx:
- Water restriction
- Second line RX (UNa+UK>150)
- Hypertonic saline/Na tablets and/or furosemide
- Correct slowly (<0.5 mEq/L/hr).
|
|
27
|
- Deficit = 0.6x70 [120-114] = 252 mmol
- Hypertonic saline required = 252/500 = 0.5 L
- Hypertonic saline required = 252x 2 =500 ml
- Quick check: To correct ΔNa of 6 requires roughly 6 x 70 ml = 420
ml hypertonic saline.
|
|
28
|
- Replace Na deficit over 12 hrs (0.5 mEq/L/hr)
- 0.5 L of 3% saline over 12 hrs = 40 ml/hr.
|